Telerehabilitation-Based Coaching Interventions (TeleSCoP) for Patients With Ischemic Stroke

Recruiting now · Not applicable

Conditions studied: Ischemic Stroke, Coaching

In brief

Ischemic stroke has high morbidity and mortality worldwide. Stroke patients experience physical, psychological, and social problems, and require rehabilitation. The aim of stroke rehabilitation is to support patients in optimizing their physical, functional, mental, social, and occupational aspects. Telerehabilitation-based coaching interventions are among the individualized interventions applied to patients. This study aimed to examine the effects of telerehabilitation-based coaching interventions on self-efficacy, modifiable risk factors, and repeated hospitalizations in patients with ischemic stroke. It is predicted that discharge education in disease management and telerehabilitation-based coaching interventions will increase self-efficacy, reduce modifiable risk factors (blood pressure, cholesterol, triglyceride, HbA1c levels, body mass index, smoking, and alcohol use), and reduce repeated hospitalizations. With an education booklet prepared for ischemic stroke patients and primary care providers, one-on-one face-to-face education is planned while patients are in the clinic on the fourth or fifth day of stroke. Determination of individual goals with motivational interview, sending educational videos prepared in cooperation with the multidisciplinary health team to the phones or e-mails of the patients, providing telerehabilitation-based coaching a total of seven times for three months after discharge, monitoring the targets set weekly and monthly, and monthly follow-up after three months. It is planned to support patients with practices such as achieving their goals, maintaining healthy lifestyle changes such as diet and physical activity, and monitoring metabolic parameters. The evaluation form of the education booklet, videos prepared with the cooperation of the multidisciplinary team, and phone call evaluation form will be evaluated by 10 experts. The preliminary application will be tested with 6 patients, and the final form will be provided. The second phase of the study was designed as a single-center, single-blind (participant), randomized controlled study. The study will be carried out with a total of 60 patients with ischemic stroke, 30 in the intervention group and 30 in the control group, who continued to be followed up and treated at the Neurology Clinic of Akdeniz University Hospital.

Key facts

Study ID

NCT05940350

Run by

Akdeniz University

People needed

60

Starts

2025-02-01

Expected to finish

2026-03-01

Last updated by the study team

2025-12-18

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients aged 45 years and older who had a stroke (the etiology of ischemic stroke can be seen at an earlier age due to hematological conditions, such as sickle cell anemia, polycythemia vera, factor deficiencies, vasculitis, and arterial dissection).
• Comply with TOAST classification criteria
• A score of "0,1,2,3" according to the Modified Rankin Scale at discharge
• Place, time, person orientation
• No communication barrier
• Turkish-speaking writer
• Having a contact phone (for phone calls)
• Support can be obtained from first-degree situations)
• Having no barriers to answering questions physically and mentally

You may not qualify if…

• Stroke of cryptogenic (etiology unknown) or non-vascular origin (tumor)
• Have a diagnosed mental or psychiatric illness*
• With dementia and cognitive deficit*
• Clinically musculoskeletal or other neurological diseases*
• With severe aphasia and dysarthria*
• With terminal illness*
• Those who score ≥ 10 according to the LACE index
• Patients whose information cannot be accessed will not be included in the study.

Where it is running

• Akdeniz University Hospital — Antalya, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.